Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deployment of a Novel NINDS Clinical, Biomarker, Imaging, and Modifiers (CBI-M) Classification Framework for ED Patients With GCS 15 TBI (PIONEER-Prognosis)

NCT07858266 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT07858266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07858266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deployment of a Novel NINDS Clinical, Biomarker, Imaging, and Modifiers (CBI-M) Classification Framework for ED Patients With GCS 15 TBI (PIONEER-Prognosis)
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
August 30, 2029
Enrollment
500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury